Published in Eur J Dermatol on May 24, 2011
Identification of a central role for complement in osteoarthritis. Nat Med (2011) 3.11
Rehabilitation treatment in patients with ankylosing spondylitis stabilized with tumor necrosis factor inhibitor therapy: a randomized controlled trial. J Rheumatol (2011) 2.45
Autophagy in human health and disease. N Engl J Med (2013) 2.04
Dermoscopic changes in melanocytic naevi in children during digital follow-up. Acta Derm Venereol (2012) 1.99
Gout: why is this curable disease so seldom cured? Ann Rheum Dis (2012) 1.84
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. J Clin Oncol (2006) 1.70
The kaleidoscope of glucorticoid effects on immune system. Autoimmun Rev (2011) 1.47
Serum amyloid-A in Behçet's disease. Clin Rheumatol (2014) 1.47
Skin cancer and other cutaneous disorders in liver transplant recipients. Acta Derm Venereol (2012) 1.41
Autoantibodies in polymyositis and dermatomyositis. Curr Rheumatol Rep (2013) 1.25
Clinical and dermatoscopic fading of post-transplant eruptive melanocytic nevi after suspension of immunosuppressive therapy. J Am Acad Dermatol (2006) 1.22
Resistant Behçet disease responsive to anakinra. Ann Intern Med (2008) 1.15
Vohwinkel syndrome: treatment of pseudo-ainhum. Int J Dermatol (2010) 1.15
OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest Group. J Rheumatol (2011) 1.14
Immunosuppression and melanocyte proliferation. Melanoma Res (2009) 1.12
Erosive osteoarthritis. Best Pract Res Clin Rheumatol (2004) 1.10
Overlap connective tissue disease syndromes. Autoimmun Rev (2012) 1.05
Pregnancy, cytokines, and disease activity in systemic lupus erythematosus. Arthritis Rheum (2004) 1.04
Bullous pemphigoid during long-term TNF-alpha blocker therapy. Dermatology (2009) 1.03
A case of malignant melanoma arising from an acquired agminated melanocytic naevus. Acta Derm Venereol (2007) 1.02
Adult-onset Still's disease with myocarditis successfully treated with the interleukin-1 receptor antagonist anakinra. Joint Bone Spine (2010) 1.02
Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease. PLoS One (2013) 1.01
Gout as autoinflammatory disease: new mechanisms for more appropriated treatment targets. Autoimmun Rev (2012) 1.00
Blau syndrome, clinical and genetic aspects. Autoimmun Rev (2012) 0.99
Inflammatory osteoarthritis of the hand. Best Pract Res Clin Rheumatol (2010) 0.99
The potential role of bone scintigraphy in the detection of deep muscular fascia involvement and calcinosis cutis in anti-synthetase syndrome. Int J Rheum Dis (2013) 0.98
Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study. Clin Exp Rheumatol (2012) 0.98
Dermatomyositis and malignancy of the pharynx in Caucasian patients: report of two observations. Rheumatol Int (2003) 0.97
International position paper on febuxostat. Clin Rheumatol (2010) 0.95
Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients. Clin Rheumatol (2014) 0.94
Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients. Clin Rheumatol (2013) 0.94
Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study. Rheumatology (Oxford) (2013) 0.94
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. Mediators Inflamm (2013) 0.93
Serpins, immunity and autoimmunity: old molecules, new functions. Clin Rev Allergy Immunol (2013) 0.93
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry. Autoimmun Rev (2012) 0.92
Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol (2004) 0.92
Anakinra treatment in drug-resistant Behcet's disease: a case series. Clin Rheumatol (2013) 0.92
Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literature. Immunol Res (2013) 0.92
Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab. Clin Exp Rheumatol (2012) 0.91
Primary cutaneous mantle cell lymphoma. Acta Derm Venereol (2011) 0.91
Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept. Autoimmun Rev (2008) 0.91
Prevalence of calcium pyrophosphate and monosodium urate crystals in synovial fluid of patients with previously diagnosed joint diseases. Joint Bone Spine (2012) 0.91
Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. Int J Rheumatol (2013) 0.91
High-density lipoproteins downregulate CCL2 production in human fibroblast-like synoviocytes stimulated by urate crystals. Arthritis Res Ther (2010) 0.90
Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for Rheumatology. Clin Exp Rheumatol (2011) 0.90
Biomechanical assessment of balance and posture in subjects with ankylosing spondylitis. J Neuroeng Rehabil (2012) 0.90
Effects of an educational-behavioral joint protection program on people with moderate to severe rheumatoid arthritis: a randomized controlled trial. Clin Rheumatol (2007) 0.90
Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR). Arthritis Res Ther (2013) 0.90
Joint and bone assessment in hand osteoarthritis. Clin Rheumatol (2013) 0.89
The effects of combined spa therapy and rehabilitation on patients with ankylosing spondylitis being treated with TNF inhibitors. Rheumatol Int (2011) 0.89
Distribution of HLA-B27 subtypes in Sardinia and continental Italy and their association with spondylarthropathies. Arthritis Rheum (2005) 0.89
Emerging and critical issues in the pathogenesis of lupus. Autoimmun Rev (2012) 0.89
Cytokine levels in human synovial fluid during the different stages of acute gout: role of transforming growth factor β1 in the resolution phase. Ann Rheum Dis (2012) 0.89
A combination therapy protocol of plasmapheresis, intravenous immunoglobulins and betamethasone to treat anti-Ro/La-related congenital atrioventricular block. A case series and review of the literature. Autoimmun Rev (2013) 0.88
YKL-40 as a marker of joint involvement in inflammatory bowel disease. Clin Chem (2003) 0.88
A new CARD15 mutation in Blau syndrome. Eur J Hum Genet (2005) 0.88
Clinical and radiographic distribution of structural damage in erosive and nonerosive hand osteoarthritis. Arthritis Care Res (Hoboken) (2012) 0.87
Elderly onset of primary Sjögren's syndrome: clinical manifestations, serological features and oral/ocular diagnostic tests. Comparison with adult and young onset of the disease in a cohort of 336 Italian patients. Joint Bone Spine (2011) 0.87
Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid. Rheumatology (Oxford) (2009) 0.87
Primary cutaneous CD30+ anaplastic large cell lymphoma in a heart transplant patient: case report and literature review. Acta Derm Venereol (2009) 0.87
Blockade of intra-articular TNF in peripheral spondyloarthritis: its relevance to clinical scores, quantitative imaging and synovial fluid and synovial tissue biomarkers. Joint Bone Spine (2012) 0.87
Serum and salivary neopterin and interferon-gamma in primary Sjögren's syndrome. Correlation with clinical, laboratory and histopathologic features. Scand J Rheumatol (2003) 0.86
Predictors of maternal and fetal complications in SLE patients: a prospective study. Immunol Res (2014) 0.86
Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study. Rheumatology (Oxford) (2010) 0.85
Epithelial CXCR3-B regulates chemokines bioavailability in normal, but not in Sjogren's syndrome, salivary glands. J Immunol (2006) 0.85
Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-α blockade in the knee joint. Arthritis Res Ther (2010) 0.85
Occurrence of squamous cell carcinoma in an area of lichen simplex chronicus: case report and pathogenetic hypothesis. J Cutan Med Surg (2012) 0.85
Methods used to assess remission and low disease activity in rheumatoid arthritis. Autoimmun Rev (2009) 0.84
Imiquimod for the treatment of classical Kaposi's sarcoma. Acta Derm Venereol (2010) 0.84
Pregnancy and vasculitis: a systematic review of the literature. Autoimmun Rev (2011) 0.84
The role of immunohistochemical analysis in the diagnosis of parapsoriasis. Acta Histochem (2010) 0.84
Targeting DSG3: from pemphigus to squamous cell carcinoma. Expert Opin Ther Targets (2013) 0.84
Facial basal cell carcinoma: analysis of recurrence and follow-up strategies. Oncol Rep (2011) 0.83
JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis. Immunol Res (2014) 0.83
Serological markers of erosive hand osteoarthritis. Eur J Intern Med (2012) 0.83
Bullous scabies simulating pemphigoid. J Cutan Med Surg (2011) 0.83
"Are there any evidences for using the intra-articular TNF-α blockade in resistant arthritis?". Joint Bone Spine (2011) 0.83
Effectiveness of different substrate materials for in vitro sunscreen tests. J Dermatol Sci (2009) 0.82
Serological markers in psoriatic arthritis: promising tools. Exp Biol Med (Maywood) (2013) 0.82
Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort. J Immunol Methods (2012) 0.82
Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) with absence of desmoglein 1 and 3 antibodies: case report and literature review. Am J Clin Dermatol (2008) 0.82
Melanoma in skin affected with keratoderma palmoplantaris hereditaria (Mal de Meleda): Treatment with excision and grafting. J Am Acad Dermatol (2009) 0.81
Plasma exchange and immunoadsorption effectively remove antiphospholipid antibodies in pregnant patients with antiphospholipid syndrome. J Clin Apher (2012) 0.81
Effect of pregnancy on serum cytokines in SLE patients. Arthritis Res Ther (2012) 0.81
The impact of knee and hip chondrocalcinosis on disability in older people: the ProVA Study from northeastern Italy. Ann Rheum Dis (2011) 0.81